Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases η and κ

Biochemistry

Volumn 45, Issue 39, 2006, Pages 12167-12174

  Yasui, Manabu ^a,b   Suzuki, Naomi ^a   Laxmi, Y R Santosh ^a   Shibutani, Shinya ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CHEMOTHERAPY; ENZYME KINETICS; GENETIC ENGINEERING; TUMORS;

BREAST CANCER; DNA ADDUCTS; DNA POLYMERASE; GENE SEQUENCE;

DNA;

ALPHA (N2 DEOXYGUANOSINYL)TAMOXIFEN; DNA DIRECTED DNA POLYMERASE ETA; DNA POLYMERASE; DNA POLYMERASE KAPPA; OLIGODEOXYNUCLEOTIDE; PHOSPHORAMIDOUS ACID; TAMOXIFEN; TAMOXIFEN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; DIASTEREOISOMER; DNA ADDUCT; DNA TEMPLATE; ENDOMETRIUM CANCER; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ONCOGENE K RAS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STEADY STATE;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEOXYRIBONUCLEOTIDES; DNA ADDUCTS; DNA-DIRECTED DNA POLYMERASE; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MUTAGENS; MUTATION; ONCOGENE PROTEIN P21(RAS); STEREOISOMERISM; TAMOXIFEN;

EID: 33749342111     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0608461     Document Type: Article

References (57)

1. Seoud, M. A.-F., Johnson, J., and Weed, J. C. (1993) Gynecologic tumors in tamoxifen-treated women with breast cancer, Obstet. Gynecol. (N.Y.) 82, 165-169.
2. van Leeuwen, F. E., Benraadt, J., Coebergh, J. W. W., Kiemeney, L. A. L. M., Diepenhorst, F. W., van den Belt-Dusebout, A. W., and van Tinteren, H. (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer, Lancet 343, 448-452.
3. Killackey, M., Hakes, T. B., and Pierce, V. K. (1985) Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens, Cancer Treat. Rep. 69, 237-238.
4. Bernstein, L., Deapen, D., Cerhan, J. R., Schwartz, S. M., Liff, J., McGann-Maloney, E., Perlman, J. A., and Ford, L. (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk, J. Natl. Cancer Inst. 91, 1654-1662.
5. Bernstein, L., Deapen, D., Cerhan, J. R., Schwartz, S. M., Liff, J., McGann-Maloney, E., Perlman, J. A., and Ford, L. (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk, J. Natl. Cancer Inst. 91, 1654-1662.
6. Han, X., and Liehr, J. G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen, Cancer Res. 52, 1360-1363.
7. Osborne, M. R., Hewer, A., Hardcastle, I. R., Carmichael, P. L., and Phillips, D. H. (1996) Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen, Cancer Res. 56, 66-71.
8. Greaves, P., Goonetilleke, R., Nunn, G., Topham, J., and Orton, T. (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wister-derived rats. Cancer Res. 53, 3919-3924.
9. Hard, G. C., Iatropoulos, M. J., Jordan, K., Radi, L., Kaltenberg, O. P., Imondi, A. R., and Williams, G. M. (1993) Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Cr1:CD(BR) rats, Cancer Res. 53, 4534-4541.
10. Kim, S. Y., Suzuki, N., Laxmi, Y. R. S., and Shibutani, S. (2004) Genotoxic mechanism of tamoxifen in developing endometrial cancer, Drug Metab. Rev. 36, 199-218.
11. Rajaniemi, H., Rasanen, I., Koivisto, P., Peltonen, K., and Hemminki, K. (1999) Identification of the major tamoxifen-DNA adducts in rats liver by mass spectroscopy, Carcinogenesis 20, 305-309.
12. 2- deoxyguanosinyl)tamoxifen N-oxide, Carcinogenesis 21, 1737-1744.
13. Umemoto, A., Komaki, K., Monden, Y., Suwa, M., Kanno, Y., Kitagawa, M., Suzuki, M., Lin, C.-X., Ueyama, Y., Momen, M. A., Ravindernath, A., and Shibutani, S. (2001) Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice, Chem. Res. Toxicol. 14, 1006-1013.
14. Shibutani, S., Suzuki, N., Laxmi, Y. R., Schild, L. J., Divi, L. J., Divi, R. L., Grollman, A. P., and Poirier, M. C. (2003) Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen, Cancer Res. 63, 4402-4406.
15. Schild, L. J., Divi, R. L., Beland, F. A., Churchwell, M. I., Doerge, D. R., Gamboa da Costa, G., Marques, M. M., and Poirier, M. C. (2003) Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days, Cancer Res. 63, 5999-6003.
16. Shibutani, S., Ravindernath, A., Suzuki, N., Terashima, I., Sugarman, S. M., Grollman, A. P., and Pearl, M. L. (2000) Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen, Carcinogenesis 21, 1461-1467.
17. Martin, E. A., Brown, K., Gaskell, M., Al-Azzawi, F., Garner, R. C., Boocock, D. J., Mattock, E., Pring, D. W., Dingley, K., Turteltaub, K. W., Smith, L. L., and White, I. N. (2003) Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry, Cancer Res. 63, 8461-8465.
18. Shibutani, S. (2005) Tamoxifen is a genotoxic carcinogen, Chem. Res. Toxicol. 18, 1509-1511.
19. Carmichael, P. L., Ugwumadu, A. H., Neven, P., Hewer, A. J., Poon, G. K., and Phillips, D. H. (1996) Lack of genotoxicity of tamoxifen in human endometrium, Cancer Res. 56, 1475-1479.
20. 32P-post-labeling for tamoxifen-DNA adducts in the human endometrium, Carcinogenesis 20, 339-342.
21. 32P-postlabeling analyses of tamoxifen-DNA adducts in humans, J. Natl. Cancer Inst. 96, 1099-1104.
22. Beland, F. A., Marques, M. M., Gamboa da Costa, G., Phillips, D. H. (2005) Tamoxifen-DNA adduct formation in human endometrium, Chem. Res. Toxicol. 18, 1507-1509.
23. Hachisuga, T., Tsujioka, H., Horiuchi, S., Udou, T., Emoto, M., and Kawarabayashi, T. (2005) K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene, Br. J. Cancer 92, 1098-1103.
24. 2-deoxyguanosinyl)tamoxifen, Biochemistry 56, 13010-13017.
25. Stygar, D., Muravitskaya, N., Eriksson, B., Eriksson, H., and Sahlin, L. (2003) Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus, Reprod. Biol. Endocrinol. 1, 1-8.
26. Goodman, M. F., and Tippin, B. (2000) The expanding polymerase universe, Nat. Rev. Mol. Cell Biol. I, 101-109.
27. Kunkel, T. A., Pavlov, Y. I., and Bebenek, K. (2003) Functions of human DNA polymerases η, κ and ι suggested by their properties, including fidelity with undamaged DNA templates, DNA Repair 3, 135-149.
28. Ohashi, E., Bebenek, K., Matsuda, T., Feaver, W. J., Gerlach, V. L., Friedberg, E. C., Ohmori, H., and Kunkel, T. A. (2000) Fidelity and processivity of DNA synthesis by DNA polymerase kappa, the product of the human DINB1 gene, J. Biol. Chem. 275, 39678-39684.
29. Zhang, Y., Yuan, F., Xin, H., Wu, X., Rajpal, D. K., Yang, D., and Wang, Z. (2000) Human DNA polymerase κ synthesizes DNA with extraordinarily low fidelity, Nucleic Acids Res. 28, 4147-4156.
30. Masutani, C., Araki, M., Yamada, A., Kusumoto, R., Nogimori, T., Maekawa, T., Iwai, S., and Hanaoka, F. (1999) Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity, EMBO J. 18, 3491-3501.
31. Johnson, R. E., Prakash, S., and Prakash, L. (1999) Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, pol η, Science 283, 1001-1004.
32. Haracska, L., Yu, S. L., Johnson, R. E., Prakash, L., and Prakash, S. (2000) Efficient and accurate replication in the presence of 7, 8-dihydro-8-oxoguanine by DNA polymerase η, Nat. Genet. 25, 458-461.
33. Masutani, C., Kusumoto, R., Iwai, S., and Hanaoka, F. (2000) Mechanisms of accurate translesion synthesis by human DNA polymerase η, EMBO J. 19, 3100-3109.
34. Zhang, Y., Yuan, F., Wu, X., Rechkoblit, O., Taylor, J. S., Geacintov, N. E., and Wang, Z. (2000) Error-prone lesion bypass by human DNA polymerase η, Nucleic Acids Res. 28, 4717-4724.
35. Ohashi, E., Ogi, T., Kusumoto, R., Iwai, S., Masutani, C., Hanaoka, F., and Ohmori, H. (2000) Error-prone bypass of certain DNA lesions by the human DNA polymerase κ, Genes Dev. 14, 1589-1594.
36. Zhang, Y., Yuan, F., Wu, X., Wang, M., Rechkoblit, O., Taylor, J.-S., Geacintov, N. E., and Wang, Z. (2000) Error-free and error-prone lesion bypass by human DNA polymerase κ in vitro, Nucleic Acids Res. 28, 4138-4146.
37. Gerlach, V. L., Feaver, W. J., Fischhaber, P. L., and Friedberg, E. C. (2001) Purification and characterization of pol κ, a DNA polymerase encoded by the human DINB1 gene, J. Biol. Chem. 276, 92-98.
38. Suzuki, N., Ohashi, E., Hayashi, K., Ohmori, H., Grollman, A. P., and Shibutani, S. (2001) Translesional synthesis past acetylaminofluorene-derived DNA adducts catalyzed by human DNA polymerase κ and Escherichia coli DNA polymerase IV, Biochemistry 40, 15176-15183.
39. 2-BPDE (7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10- tetrahydrobenzo-[a]pyrene), Biochemistry 41, 6100-6106.
40. Gerlach, V. L., Aravind, L., Gotway, G., Schultz, R. A., Koonin, E. V., and Friedberg, E. C. (1999) Human and mouse homologs of Escherichia coli DinB (DNA polymerase IV), members of the UmuC/DinB superfamily, Proc. Natl. Acad. Sci. U.S.A. 96, 11922-11927.
41. Ogi, T., Kato, Jr., T., Kato, T., and Ohmori, H. (1999) Mutation enhancement by DINB1, a mammalian homologue of the Escherichia coli mutagenesis protein dinB, Genes Cells 4, 607-618.
42. Velasco-Miguel, S., Richardson, J. A., Gerlach, V. L., Lai, W. C., Gao, T., Russell, L. D., Hladik, C. L., White, C. L., and Friedberg, E. C. (2003) Constitutive and regulated expression of the mouse Dinb (Pol κ) gene encoding DNA polymerase κ, DNA Repair 2, 91-106.
43. Yamada, A., Masutani, C., Iwai, S., and Hanaoka, F. (2000) Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase κ, Nucleic Acids Res. 28, 2473-2480.
44. Kawamura, K., Bahar, R., Seimiya, M., Chiyo, M., Wada, A., Okada, S., Hatano, M., Tokuhisa, T., Kimura, H., Watanabe, S., Honda, I., Sakiyama, S., Tagawa, M., and O-Wang, J. (2004) DNA polymerase θ is preferentially expressed in lymphoid tissues and upregulated in human cancers, Int. J. Cancer 109, 9-16.
45. 4-etheno-2′-deoxycytidine in reactions catalyzed by mammalian DNA polymerases, Biochemistry 35, 14992-14998.
46. 2-2′-deoxyguanosinyl)tamoxifen by phosphoramidite chemical synthesis, Chem. Res. Toxicol. 15, 218-225.
47. 2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen, Cancer Res. 59, 2091-2095.
48. Shibutani, S. (1993) Quantitation of base substitutions and deletions induced by chemical mutagens during DNA synthesis in vitro, Chem. Res. Toxicol. 6, 625-629.
49. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
50. Mendelman, L. V., Boosalis, M. S., Petruska, J., and Goodman, M. F. (1989) Nearest neighbor influences on DNA polymerase insertion fidelity, J. Biol. Chem. 264, 14415-14423.
51. Mendelman, L. V., Petruska, J., and Goodman, M. F. (1990) Base mispair extension kinetics, J. Biol. Chem. 265, 2338-2346.
52. Clark, J. M., Joyce, C. M., and Beardsley, G. P. (1987) Novel blunt-end addition reactions catalyzed by DNA polymerase I of Escherichia coli, J. Mol. Biol. 198, 123-127.
53. 6-(2-hydroxyestron-6-yl)-2′-deoxyadenosine, Biochemistry 37, 13807-13815.
54. Suzuki, N., Itoh, S., Poon, K., Masutani, C., Hanaoka, F., Ohmori, H., Yoshizawa, I., and Shibutani, S. (2004) Translesion synthesis past estrogen-derived DNA adducts by human DNA polymerases ζ and κ, Biochemistry 43, 6304-6311.
55. 2-guanine adduct within a bent and widened DNA minor groove, J. Mol. Biol. 302, 377-393.
56. Frank, E. G., Tissier, A., McDonald, J. P., Rapić-Otrin, V., Zeng, X., Gearhart, P. J., and Woodgate, R. (2001) Altered nucleotide misinsertion fidelity associated with poliota-dependent replication at the end of a DNA template, EMBO J. 20, 2914-2922.
57. 2-yl)-2-acetylaminofluorene, a persistent acetylaminofluorene-derived DNA adduct in mammalian cells, Biochemistry 43, 15005-15013.